BACKGROUND: Microneedle-mediated drug delivery is a promising method for transdermal delivery of insulin, incretin mimetics, and other protein-based pharmacologic agents for treatment of diabetes mellitus. One factor that has limited clinical application of conventional microneedle technology is the poor fracture behavior of microneedles that are created using conventional materials and methods. In this study polymer microneedles for transdermal delivery were created using a two-photon polymerization (2PP) microfabrication and subsequent polydimethylsiloxane (PDMS) micromolding process. METHODS: Solid microneedle arrays, fabricated by means of 2PP, were used to create negative molds from PDMS. Using these molds microneedle arrays were subsequently prepared by molding eShell 200, a photo-reactive acrylate-based polymer that exhibits water and perspiration resistance. RESULTS: The eShell 200 microneedle array demonstrated suitable compressive strength for use in transdermal drug delivery applications. Human epidermal keratinocyte viability on the eShell 200 polymer surfaces was similar to that on polystyrene control surfaces. In vitro studies demonstrated that eShell 200 microneedle arrays fabricated using the 2PP microfabrication and PDMS micromolding process technique successfully penetrated human stratum corneum and epidermis. CONCLUSIONS: Our results suggest that a 2PP microfabrication and subsequent PDMS micromolding process may be used to create microneedle structures with appropriate structural, mechanical, and biological properties for transdermal drug delivery of insulin and other protein-based pharmacologic agents for treatment of diabetes mellitus. (c) 2009 Diabetes Technology Society.
BACKGROUND: Microneedle-mediated drug delivery is a promising method for transdermal delivery of insulin, incretin mimetics, and other protein-based pharmacologic agents for treatment of diabetes mellitus. One factor that has limited clinical application of conventional microneedle technology is the poor fracture behavior of microneedles that are created using conventional materials and methods. In this study polymer microneedles for transdermal delivery were created using a two-photon polymerization (2PP) microfabrication and subsequent polydimethylsiloxane (PDMS) micromolding process. METHODS: Solid microneedle arrays, fabricated by means of 2PP, were used to create negative molds from PDMS. Using these molds microneedle arrays were subsequently prepared by molding eShell 200, a photo-reactive acrylate-based polymer that exhibits water and perspiration resistance. RESULTS: The eShell 200 microneedle array demonstrated suitable compressive strength for use in transdermal drug delivery applications. Human epidermal keratinocyte viability on the eShell 200 polymer surfaces was similar to that on polystyrene control surfaces. In vitro studies demonstrated that eShell 200 microneedle arrays fabricated using the 2PP microfabrication and PDMS micromolding process technique successfully penetrated human stratum corneum and epidermis. CONCLUSIONS: Our results suggest that a 2PP microfabrication and subsequent PDMS micromolding process may be used to create microneedle structures with appropriate structural, mechanical, and biological properties for transdermal drug delivery of insulin and other protein-based pharmacologic agents for treatment of diabetes mellitus. (c) 2009 Diabetes Technology Society.
Authors: Devin V McAllister; Ping M Wang; Shawn P Davis; Jung-Hwan Park; Paul J Canatella; Mark G Allen; Mark R Prausnitz Journal: Proc Natl Acad Sci U S A Date: 2003-11-17 Impact factor: 11.205
Authors: J Serbin; A Egbert; A Ostendorf; B N Chichkov; R Houbertz; G Domann; J Schulz; C Cronauer; L Fröhlich; M Popall Journal: Opt Lett Date: 2003-03-01 Impact factor: 3.776
Authors: A Doraiswamy; C Jin; R J Narayan; P Mageswaran; P Mente; R Modi; R Auyeung; D B Chrisey; A Ovsianikov; B Chichkov Journal: Acta Biomater Date: 2006-03-15 Impact factor: 8.947
Authors: Wijaya Martanto; Shawn P Davis; Nicholas R Holiday; Jenny Wang; Harvinder S Gill; Mark R Prausnitz Journal: Pharm Res Date: 2004-06 Impact factor: 4.200
Authors: Shaun D Gittard; Aleksandr Ovsianikov; Hasan Akar; Boris Chichkov; Nancy A Monteiro-Riviere; Shane Stafslien; Bret Chisholm; Chun-Che Shin; Chun-Ming Shih; Shing-Jong Lin; Yea-Yang Su; Roger J Narayan Journal: Adv Eng Mater Date: 2010-04 Impact factor: 3.862
Authors: Gabriela Valdés-Ramírez; Joshua R Windmiller; Jonathan C Claussen; Alexandra G Martinez; Filiz Kuralay; Ming Zhou; Nandi Zhou; Ronen Polsky; Philip R Miller; Roger Narayan; Joseph Wang Journal: Sens Actuators B Chem Date: 2012-01-03 Impact factor: 7.460
Authors: Philip R Miller; Shaun D Gittard; Thayne L Edwards; Deanna M Lopez; Xiaoyin Xiao; David R Wheeler; Nancy A Monteiro-Riviere; Susan M Brozik; Ronen Polsky; Roger J Narayan Journal: Biomicrofluidics Date: 2011-03-30 Impact factor: 2.800
Authors: Shaun D Gittard; Bo Chen; Huadong Xu; Aleksandr Ovsianikov; Boris N Chichkov; Nancy A Monteiro-Riviere; Roger J Narayan Journal: J Adhes Sci Technol Date: 2012-08-06 Impact factor: 2.077
Authors: Shaun D Gittard; Philip R Miller; Ryan D Boehm; Aleksandr Ovsianikov; Boris N Chichkov; Jeremy Heiser; John Gordon; Nancy A Monteiro-Riviere; Roger J Narayan Journal: Faraday Discuss Date: 2011 Impact factor: 4.008
Authors: Shaun D Gittard; Aleksandr Ovsianikov; Boris N Chichkov; Anand Doraiswamy; Roger J Narayan Journal: Expert Opin Drug Deliv Date: 2010-04 Impact factor: 6.648
Authors: S D Gittard; R J Narayan; C Jin; A Ovsianikov; B N Chichkov; N A Monteiro-Riviere; S Stafslien; B Chisholm Journal: Biofabrication Date: 2009-12 Impact factor: 9.954